Remifentanil vs. dexmedetomidine for cardiac surgery patients with noninvasive ventilation intolerance: a multicenter randomized controlled trial

Remifentanil vs. dexmedetomidine for cardiac surgery patients with noninvasive ventilation intolerance: a multicenter randomized controlled trial

Abstract Background The optimal sedative regime for noninvasive ventilation (NIV) intolerance remains uncertain. The present study aimed to assess the efficacy and safety of remifentanil (REM) compared to dexmedetomidine (DEX) in cardiac surgery patients with moderate-to-severe intolerance to NIV. M...

Full description

Bibliographic Details
Main Authors: Guang-wei Hao, Jia-qing Wu, Shen-ji Yu, Kai Liu, Yan Xue, Qian Gong, Rong-cheng Xie, Guo-guang Ma, Ying Su, Jun-yi Hou, Yi-jie zhang, Wen-jun Liu, Wei Li, Guo-wei Tu, Zhe Luo
Format: Article
Language:English
Published: BMC 2024-09-01
Series:Journal of Intensive Care
Subjects:
Remifentanil
Dexmedetomidine
Non-invasive ventilation intolerance
Cardiac surgery
Online Access:https://doi.org/10.1186/s40560-024-00750-2

Internet

https://doi.org/10.1186/s40560-024-00750-2

Similar Items